Aspirin Benefit In Breast Cancer Risk Linked To Hormone Receptivity – JAMA
This article was originally published in The Tan Sheet
Executive Summary
A potential chemopreventive effect of aspirin and other NSAIDs on breast cancer may be linked to the hormone receptor status of the tumor, researchers reported in the May 26 Journal of the American Medical Association
You may also be interested in...
NSAID/Breast Cancer Study Joins Inconsistent Body Of Data On Relationship
Long-term, daily aspirin and ibuprofen use are linked to an increased risk of breast cancer in a recent epidemiologic study by Sarah Marshall, University of Southern California, et al.
NSAID/Breast Cancer Study Joins Inconsistent Body Of Data On Relationship
Long-term, daily aspirin and ibuprofen use are linked to an increased risk of breast cancer in a recent epidemiologic study by Sarah Marshall, University of Southern California, et al.
NSAID/Breast Cancer Study Joins Inconsistent Body Of Data On Relationship
Long-term, daily aspirin and ibuprofen use are linked to an increased risk of breast cancer in a recent epidemiologic study by Sarah Marshall, University of Southern California, et al.